HCEMM research groups are pursuing research and development in cross cutting fields. Their activities are reviewed every 5 years in order to ensure scientific excellence. HCEMM focuses on and supports molecular medicine-oriented research activities targeting key, highly prevalent ageing-related non-communicable diseases. The organizational and management model ensures autonomy and scientific excellence with an international evaluation system.